Niagen Bioscience, Inc. (NAGE) Shareholders’ equity 2017–2025
Niagen Bioscience, Inc. (NAGE) shareholders’ equity at each fiscal year-end, per SEC filings.
$76.5MFY2025 · since FY2017: $53.8M → $76.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $76.5M | +66.0% |
| FY2024 | $46.1M | +62.0% |
| FY2023 | $28.5M | -0.8% |
| FY2022 | $28.7M | -9.6% |
| FY2021 | $31.7M | +93.2% |
| FY2020 | $16.4M | -19.7% |
| FY2019 | $20.4M | -24.8% |
| FY2018 | $27.2M | -49.5% |
| FY2017 | $53.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice